AbbVie Demonstrates Leadership in HCV with New MAVYRET glecaprevir/pibrentasvir Data to be Presented at The Liver Meeting 2017

Press/Media: Press / Media

PeriodOct 23 2017

Media coverage

1

Media coverage

  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET glecaprevir/pibrentasvir Data to be Presented at The Liver Meeting 2017
    Media name/outletPharmacy Choice
    CountryUnited States
    Date10/23/17
    PersonsFred Poordad